Literature DB >> 21630302

Fetal hemoglobin in sickle cell anemia: Saudi patients from the Southwestern province have similar HBB haplotypes but higher HbF levels than African Americans.

Abdulrahman Alsultan1, Nadia Solovieff, Aamer Aleem, Farjah H AlGahtani, Ali Al-Shehri, Mohamed Elfaki Osman, Kadijah Kurban, Hasan Bahakim, Abdul Kareem Al-Momen, Clinton T Baldwin, David H K Chui, Martin H Steinberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21630302     DOI： 10.1002/ajh.22032

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  14 in total

1.  Prothrombin 20210G>A genotype and C-reactive protein level.

Authors:  Berthold Hoppe; Gerd-Rüdiger Burmester; Thomas Häupl
Journal:  Blood       Date:  2011-10-20       Impact factor: 22.113

Review 2.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 3.  Fetal hemoglobin in sickle cell anemia.

Authors:  Idowu Akinsheye; Abdulrahman Alsultan; Nadia Solovieff; Duyen Ngo; Clinton T Baldwin; Paola Sebastiani; David H K Chui; Martin H Steinberg
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

4.  Genetic determinants of HbF in Saudi Arabian and African Benin haplotype sickle cell anemia.

Authors:  Elmutaz M Shaikho; John J Farrell; Abdulrahman Alsultan; Paola Sebastiani; Martin H Steinberg
Journal:  Am J Hematol       Date:  2017-07-19       Impact factor: 10.047

Review 5.  Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.

Authors:  Alawi H Habara; Elmutaz M Shaikho; Martin H Steinberg
Journal:  Am J Hematol       Date:  2017-08-17       Impact factor: 10.047

Review 6.  Fetal hemoglobin in sickle cell anemia.

Authors:  Martin H Steinberg
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

7.  BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.

Authors:  P Sebastiani; J J Farrell; A Alsultan; S Wang; H L Edward; H Shappell; H Bae; J N Milton; C T Baldwin; A M Al-Rubaish; Z Naserullah; F Al-Muhanna; A Alsuliman; P K Patra; L A Farrer; D Ngo; V Vathipadiekal; D H K Chui; A K Al-Ali; M H Steinberg
Journal:  Blood Cells Mol Dis       Date:  2015-01-30       Impact factor: 3.039

Review 8.  Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Authors:  Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Paediatr Respir Rev       Date:  2013-11-15       Impact factor: 2.726

9.  Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.

Authors:  Abdulrahman Alsultan; Mohammed K Alabdulaali; Paula J Griffin; Ahmed M Alsuliman; Hazem A Ghabbour; Paola Sebastiani; Waleed H Albuali; Amein K Al-Ali; David H K Chui; Martin H Steinberg
Journal:  Br J Haematol       Date:  2013-11-13       Impact factor: 6.998

Review 10.  Genomic approaches to identifying targets for treating β hemoglobinopathies.

Authors:  Duyen A Ngo; Martin H Steinberg
Journal:  BMC Med Genomics       Date:  2015-07-29       Impact factor: 3.063
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.